The FDA has started a priority review of Insmed's brensocatib, which is pitching to become the first approved therapy for bronchiectasis in the US.

Introduction Acute bronchitis is a self-limiting infection of the large airways; cough is the primary symptom, usually lasting for about 3 weeks. Annually, approximately 5% of adults develop acute ...

Acute bronchitis: A viral infection that inflames the larger airways, leading to chest discomfort, fatigue, and a persistent cough with mucus. People often call this a "chest cold." Lung abscess: A ...